Burosumab
Burosumab (KRN23) is a human monoclonal antibody targeting fibroblast growth factor 23 (FGF23) for the treatment of cutaneous-skeletal hypophosphatemic syndrome (CSHS) and tumor-induced osteochondrosis.
Product Specifications
CAS Number
1610833-03-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
248650-AP 100 µL
MEF2B (Myocyte Enhancer Factor 2B, FLJ32599, FLJ46391, MGC189732, MGC189763, RSRFR2) (AP) discontinued
Ask
View Details 
GTR15105043 1 Vial
Lentiviral human MGST2 shRNA (UAS) - Lentiviral human MGST2 shRNA (UAS) plasmid
Ask
View Details 356348-01 48 Tests
HRH4 (Histamine Receptor H4) BioAssayTM ELISA Kit (Rat) discontinued
Ask
View Details 356348-02 96 Tests
HRH4 (Histamine Receptor H4) BioAssayTM ELISA Kit (Rat) discontinued
Ask
View Details